International Steering Committee to discontinue the trial’s hydroxychloroquine and the lopinavir/ritonavir arms.
Interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized #COVID19 patients when compared to the existing standard of care.
The Solidarity Trial was established by WHO to find an effective #COVID19 treatment for hospitalized patients.
Copyright: Fresh Angle International (www.freshangleng.com)
ISSN 2354 - 4104
Sponsored Ad
Our strategic editorial policy of promoting journalism, anchored on the tripod of originality, speed and efficiency, would be further enhanced with your financial support.
Your kind contribution, to our desire to become a big global brand, should be credited to our account:
Fresh Angle Nig. Ltd
ACCOUNT NUMBER: 0130931842.
BANK GTB.
×
![]()